RE:Q2The stand out this quarter was the cost of sales which really balooned so every gram sold is a loss on the top line and gets worse from there.
It would be interesting to know why, maybe the answer is in the md&a but I don't care enough to glean through it.
NAV stable at .06-10c/share depending on the intangibles.
No reason to buy at this point so wait yet another quarter in a bad MJ and stock markets.